menu
    • menu

    Company profile for InterCure

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InterCureIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    85 Medinat ha-Yehudim Street Herzliya
    Telephone
    Telephone
    201-720-7750
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.intercure.co/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InterCure Notified By Nasdaq On Minimum Bid Requirement
    InterCure Notified By Nasdaq On Minimum Bid Requirement

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248978/0/en/InterCure-Receives-Nasdaq-Notification-Regarding-Minimum-Bid-Requirement.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    InterCure Sees 2025 Revenue at NIS 265M
    InterCure Sees 2025 Revenue at NIS 265M

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240919/0/en/InterCure-Announces-Preliminary-Estimated-2025-Revenue-of-NIS-265-Million-Positive-Adjusted-EBITDA-and-Cash-of-NIS-43-Million.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Intercure, Cannasoul Ink Deals To Boost Cannabis Pharma
    Intercure, Cannasoul Ink Deals To Boost Cannabis Pharma

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179258/0/en/InterCure-and-Cannasoul-Sign-Strategic-Investment-and-Collaboration-Agreements-to-Advance-Cannabis-Science-and-Pharmaceutical-Innovation.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    InterCure Reports H1 2025 Revenue of NIS 130M, Positive Cash Flow
    InterCure Reports H1 2025 Revenue of NIS 130M, Positive Cash Flow

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163467/0/en/InterCure-Reports-First-Half-2025-Results-with-NIS-130-Million-in-Revenue-and-Positive-Operating-Cash-Flow.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    InterCure Acquires ISHI to Unlock US Cannabis Tech Access
    InterCure Acquires ISHI to Unlock US Cannabis Tech Access

    19 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/19/3153163/0/en/InterCure-Announces-Strategic-Acquisition-of-ISHI-Unlocking-Access-to-Premium-U-S-Cannabis-Technology-and-Brands.html

    GLOBENEWSWIRE
    19 Sep 2025
    Share Share
    InterCure Expands Cookies Partnership To Germany
    InterCure Expands Cookies Partnership To Germany

    28 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240828846979/en

    BUSINESSWIRE
    28 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search